Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment

MLA

Winkel, Dennis, et al. Target Coverage and Dose Criteria Based Evaluation of the First Clinical 1.5T MR-Linac SBRT Treatments of Lymph Node Oligometastases Compared with Conventional CBCT-Linac Treatment. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1150256473&authtype=sso&custid=ns315887.

APA

Winkel, D., Bol, G. H., Werensteijn-Honingh, A. M., Intven, M. P. W., Eppinga, W. S. C., Hes, J., Snoeren, L. M. W., Sikkes, G. G., Gadellaa-van Hooijdonk, C. G. M., Raaymakers, B. W., Jürgenliemk-Schulz, I. M., & Kroon, P. S. (2020). Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.

Chicago

Winkel, Dennis, Gijsbert H. Bol, Anita M. Werensteijn-Honingh, Martijn P.W. Intven, Wietse S.C. Eppinga, Jochem Hes, Louk M.W. Snoeren, et al. 2020. “Target Coverage and Dose Criteria Based Evaluation of the First Clinical 1.5T MR-Linac SBRT Treatments of Lymph Node Oligometastases Compared with Conventional CBCT-Linac Treatment.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1150256473&authtype=sso&custid=ns315887.